Genetics, Parkinson's disease, Disease, Parkinsonism and Genome-wide association study are his primary areas of study. His work in Genetics addresses issues such as Parkin, which are connected to fields such as Point mutation, Mitochondrion and Age of onset. Parkinson's disease is a subfield of Internal medicine that Thomas Gasser investigates.
His research investigates the connection with Disease and areas like Psychiatry which intersect with concerns in Intensive care medicine. Thomas Gasser interconnects Gene duplication, Exome sequencing, Spect imaging and Locus in the investigation of issues within Parkinsonism. His Genome-wide association study research includes themes of Meta-analysis, Genetic heterogeneity, Genetic association and Allele frequency.
Thomas Gasser mainly focuses on Genetics, Parkinson's disease, Disease, Internal medicine and LRRK2. His is involved in several facets of Genetics study, as is seen by his studies on Gene, Genome-wide association study, Single-nucleotide polymorphism, Locus and Mutation. His Genome-wide association study research focuses on Genetic association and how it connects with Heritability.
Thomas Gasser focuses mostly in the field of Parkinson's disease, narrowing it down to topics relating to Parkinsonism and, in certain cases, Parkin, Central nervous system disease and Dystonia. The study incorporates disciplines such as Immunology, Pathogenesis, Bioinformatics and Cohort in addition to Disease. His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology, Endocrinology, Oncology and Pathology.
The scientist’s investigation covers issues in Disease, Parkinson's disease, Genetics, Internal medicine and LRRK2. His Disease research includes elements of Genome-wide association study, Cerebrospinal fluid, Mutation, Genetic association and Cohort. His study in Parkinson's disease is interdisciplinary in nature, drawing from both Glucocerebrosidase, Penetrance, Parkinsonism and Cell biology.
His Genetics study often links to related topics such as Dystonia. The various areas that he examines in his Internal medicine study include Endocrinology, Oncology and Genotype. His LRRK2 research incorporates elements of Cellular differentiation, Bioinformatics, Signal transduction, Kinase activity and Gene duplication.
Thomas Gasser mainly investigates Disease, Parkinson's disease, Genetics, Gene and LRRK2. His Disease research integrates issues from Cerebrospinal fluid, Neuroscience, Genetic association and Bioinformatics. Thomas Gasser interconnects Cell biology, Disease duration, Parkinsonism and Mitochondrial biogenesis in the investigation of issues within Parkinson's disease.
His study on Genome-wide association study and Glucocerebrosidase is often connected to Context as part of broader study in Genetics. The Genome-wide association study study which covers Age of onset that intersects with Lewy body. In the subject of general Gene, his work in Mutation and Exome sequencing is often linked to Metal ion transport, thereby combining diverse domains of study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology
Alexander Zimprich;Alexander Zimprich;Saskia Biskup;Petra Leitner;Peter Lichtner.
MDS clinical diagnostic criteria for Parkinson's disease
Ronald B. Postuma;Daniela Berg;Matthew Stern;Werner Poewe.
Movement Disorders (2015)
The ubiquitin pathway in Parkinson's disease
Elisabeth Leroy;Rebecca Boyer;Georg Auburger;Barbara Leube.
Association between Early-Onset Parkinson's Disease and Mutations in the Parkin Gene
CB Lucking;A Durr;Bonifati;J Vaughan.
The New England Journal of Medicine (2000)
Genome-wide association study reveals genetic risk underlying Parkinson's disease
Javier Simón-Sánchez;Claudia Schulte;Jose M Bras;Jose M Bras;Manu Sharma.
Nature Genetics (2009)
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
Ellen Sidransky;Michael A. Nalls;Jan O. Aasly;Judith Aharon-Peretz.
The New England Journal of Medicine (2009)
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
Daniel G Healy;Mario Falchi;Sean S O'Sullivan;Vincenzo Bonifati.
Lancet Neurology (2008)
Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies.
Michael A. Nalls;Vincent Plagnol;Dena G. Hernandez;Dena G. Hernandez;Manu Sharma;Manu Sharma.
The Lancet (2011)
MDS research criteria for prodromal Parkinson's disease
Daniela Berg;Ronald B. Postuma;Charles H. Adler;Bastiaan R. Bloem.
Movement Disorders (2015)
The phenotypic spectrum of CADASIL: clinical findings in 102 cases.
M. Dichgans;M. Mayer;I. Uttner;R. Brüning.
Annals of Neurology (1998)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: